Long-term outcomes of sacral neuromodulation for lower urinary tract dysfunction: A 23-year experience
- PMID: 33232534
- DOI: 10.1002/nau.24583
Long-term outcomes of sacral neuromodulation for lower urinary tract dysfunction: A 23-year experience
Abstract
Aims: To evaluate the long-term outcomes of sacral neuromodulation (SNM), and patient characteristics that may predict long-term success or complications.
Methods: A single-center retrospective cohort study was performed of all patients who underwent SNM testing and implantation. Outcome results, resolution of symptoms, and device removal were reported. Multivariable logistic regression was used to identify predictors of success. Cox proportional hazards model was used to identify predictors for device removal.
Results: Four hundred and thrity four patients underwent SNM test phase of which 241 (median age 48.0 years, 91.7% [221/241] female) had device implantation and were followed up for median [range] time of 4.0 (3 months-20.5 years) years. Multivariable logistic regression showed that male gender (odds ratio: 0.314; 95% confidence interval: 0.164-0.601, p = .0005) was independently associated with decreased peripheral nerve evaluation success. At final follow-up for patients who originally had device implantation, median (interquartile range) percent of symptoms resolution of all patients was 60.0% (0%-90%) and 69.3% (167/241) had SNM successful outcomes. Cox proportional hazards model showed no difference for time to SNM device removal with respect to patient age, gender, or diagnosis. 69.3% (167/241) patients had at least 1 surgical re-intervention. The most common reason at first surgical re-intervention was lead change only (26.3%, 44/167).
Conclusion: SNM is a minimally invasive procedure with good long-term success rates. There is a high revision rate but overall, SNM has a good safety profile and excellent long-term outcomes.
Keywords: electric stimulation; interstitial cystitis; overactive bladder; sacral neuromodulation; urinary bladder.
© 2020 Wiley Periodicals LLC.
Comment in
-
Sacral neuromodulation for LUTS has promising long-term outcomes.Nat Rev Urol. 2021 Feb;18(2):72. doi: 10.1038/s41585-021-00424-w. Nat Rev Urol. 2021. PMID: 33408354 No abstract available.
-
Voiding Function and Dysfunction, Bladder Physiology and Pharmacology, and Female Urology.J Urol. 2022 Feb;207(2):470-475. doi: 10.1097/JU.0000000000002327. Epub 2021 Nov 17. J Urol. 2022. PMID: 34784730 No abstract available.
References
REFERENCES
-
- Marcelissen TA, Leong RK, de Bie RA, van Kerrebroeck PE, de Wachter SG. Long-term results of sacral neuromodulation with the tined lead procedure. J Urol. 2010;184:1997-2000.
-
- Kessler TM, Fowler CJ. Sacral neuromodulation for urinary retention. Nat Clin Pract Urol. 2008;5:657-66.
-
- Elkelini MS, Abuzgaya A, Hassouna MM. Mechanisms of action of sacral neuromodulation. Int Urogynecol J. 2010;21:439-46.
-
- Al-Zahrani AA, Elzayat EA, Gajewski JB. Long-term outcome and surgical interventions after sacral neuromodulation implant for lower urinary tract symptoms: 14-year experience at 1 center. J Urol. 2011;185:981-986.
-
- Haylen BT, De Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29:4-20.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
